Diosmin protects against ethanol-induced hepatic injury via alleviation of inflammation and regulation of TNF-α and NF-κB activation

Alcohol

Volumn 47, Issue 2, 2013, Pages 131-139

  Tahir, Mir ^a   Rehman, Muneeb U ^a   Lateef, Abdul ^a   Khan, Rehan ^a   Khan, Abdul Quaiyoom ^a   Qamar, Wajhul ^a   Ali, Farrah ^a   O'Hamiza, Oday ^a   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Alcohol dehydrogenase; Cyclooxygenase 2; Cytochrome P450 2E1; Ethanol; Tumor necrosis factor alpha

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALCOHOL DEHYDROGENASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CYCLOOXYGENASE 2; CYTOCHROME P450 2E1; DIOSMIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; LIVER WEIGHT; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WEIGHT REDUCTION;

ALCOHOL DEHYDROGENASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CATALASE; CYCLOOXYGENASE 2; CYTOCHROME P-450 CYP2E1; DIOSMIN; ETHANOL; FEMALE; INFLAMMATION; LIVER; LIVER DISEASES, ALCOHOLIC; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874008538     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2012.12.010     Document Type: Article

References (53)

1. Arteel G.E. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 2003, 124:778-790.
2. Aruna K., Rukkumani P., Varma S.P., Menon V.P. Therapeutic role of Cuminum cyminum on ethanol and thermally oxidized sunflower oil induced toxicity. Phytotherapy Research 2005, 19:416-421.
3. Athar M., Sharma S.D., Iqbal M., Sultana S., Pandaya K.B., Tripathi I.P. Coordination of copper polyamines complex with imidazoles potentiates its superoxide dismutase mimicking activity and abolishes its interactions with albumin. Biochemistry & Molecular Biology International 1996, 39:813-821.
4. Baldi E., Burra P., Plebani M., Salvagnini M. Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease. Italian Journal of Gastroenterology 1993, 25:429-432.
5. Baliunas D.O., Taylor B.J., Irving H., Roerecke M., Patra J., Mohapatra S., et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2009, 32:2123-2132.
6. Barnes P.J., Karin M. Nuclear factor kB-a pivotal factor in chronic inflammatory diseases. New England Journal of Medicine 1997, 336:1066-1071.
7. Bonnichsen R.K., Brink N.G. Liver alcohol dehydrogenases. Methods in Enzymology 1955, 1:495-500.
8. Bradford B.U., Seed C.B., Handler J.A., Forman D.T., Thurman R.G. Evidence that catalase is a major pathway of ethanol oxidation in vivo: dose-response studies in deer mice using methanol as selective substrate. Archives of Biochemistry and Biophysics 1993, 303:172-176.
9. Brooks P.J., Theruvathu J.A. DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 2005, 35:187-193.
10. Campanero M.A., Escolar M., Garcia-Quetglas P., Sadaba B., Azanza J.R. Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: application to a clinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2010, 51:875-881.
11. Carlberg, Mannervik B. Glutathione level in rat brain. Journal of Biological Chemistry 1975, 250:4480-4575.
12. Cederbaum A.I. Introduction serial review: alcohol, oxidative stress and cell injury. Free Radical Biology and Medicine 2001, 31:1524-1526.
13. Cederbaum A.I., Lu Y., Wu D. Role of oxidative stress in alcohol-induced liver injury. Archives of Toxicology 2009, 83:519-548.
14. Chen Y., Cui L., Liao J., Huang L. Effects of alcohol on bone metabolism and biomechanical property of mice. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2009, 26:780-782.
15. Claiborne A. Catalase activity. Handbook of methods in oxygen radical research 1985, 283-284. CRC Press, Boca Raton. R.A. Greenwald (Ed.).
16. Cotelle N., Bernier J.L., Catteau J.P., Pommery J., Wallet J.C., Gaydou E.M. Antioxidant properties of hydroxy-flavones. Free Radical Biology and Medicine 1996, 20:35-43.
17. Crespo M.E., Gálvez J., Cruz T., Ocete M.A., Zarzuelo A. Anti-inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS. Planta Medica 1999, 65:651-653.
18. Gao B., Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011, 141:1572-1585.
19. George A., Figueredo V.M. Alcohol and arrhythmias: a comprehensive review. Journal of Cardiovascular Medicine 2010, 11:221-228.
20. Guidot D.M., Roman J. Chronic ethanol ingestion increases susceptibility to acute lung injury. Chest 2002, 122:309-314.
21. Guo R., Ren J. Alcohol and acetaldehyde in public health: from marvel to menace. International Journal of Environmental Research and Public Health 2010, 7:1285-1301.
22. Hayes J.D., Pulford D.J. The glutathione-S-transferase supergene family: regulation of GST and the contribution of isoenzymes to cancer protection and drug resistance. Critical Reviews in Biochemistry and Molecular Biology 1995, 35:445-600.
23. Honchel R., Ray M.B., Marsano L., Cohen D., Lee E., Shedlofsky S., et al. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcoholism: Clinical and Experimental Research 1992, 16:665-669.
24. Iimuro Y., Gallucci R.M., Luster M.I., Kono H., Thurman R.G. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997, 26:1530-1537.
25. Ji C., Deng Q., Kaplowitz N. Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. Hepatology 2004, 40:442-451.
26. Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobezene oxide as the hepatotoxic metabolite. Pharmacology 1974, 11:151.
27. Kornberg A. Lactic dehydrogenase of muscle. Methods in enzymology 1955, 441-443. Academic Press, New York. S.P. Colowick, N.O. Kaplan (Eds.).
28. Lieber C.S. Biochemical and molecular basis of alcohol induced injury to liver and others tissues. New England Journal of Medicine 1988, 319:1639-1650.
29. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34:9-19.
30. Lieber C.S. Metabolism of alcohol. Clinics in Liver Disease 2005, 9:1-35.
31. Lowry O.H., Rosebrough N.J., Farr A., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
32. Lu Y., Cederbaum A.I. CYP2E1 and oxidative liver injury by alcohol. Free Radical Biology and Medicine 2008, 44:723-738.
33. Lucey M.R., Weinrieb R.M. Alcohol and substance abuse. Seminars in Liver Disease 2009, 29:66-73.
34. Lyseng-Williamson K.A., Perry C.M. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs 2003, 63:71-100.
35. Manuel Y., Keenoy B., Vertommen J., De Leeuw I. The effect of flavonoid treatment on the glycation and antioxidant status in type 1 diabetic patients. Diabetes, Nutrition & Metabolism 1999, 12:256-263.
36. Marinho V., Laks J., Engelhardt E., Conn D. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease. Journal of Clinical Psychopharmacology 2006, 26:683-685.
37. Mohandas M., Marshall J.J., Duggin G.G., Horvath J.S., Tiller D. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney. Cancer Research 1984, 44:5086-5091.
38. Morris M.J. Alcohol breath testing in patients with respiratory disease. Thorax 1990, 45:717-721.
39. Nanji A.A., French S.W. Animal models of alcoholic liver disease - focus on the intragastric feeding model. Alcohol Research & Health 2003, 27:325-330.
40. Nanji A.A., Jokelainen K., Rahemtulla A., Miao L., Fogt F., Matsumoto H., et al. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in rat. Hepatology 1999, 30:934-943.
41. Nanji A.A., Jokelainen K., Tipoe G.L., Rahemtulla A., Thomas P., Dannenberg A.J. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. American Journal of Physiology. Gastrointestinal and Liver Physiology 2003, 284:321-327.
42. Niemelä O. Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Frontiers in Bioscience 1999, 4:506-513.
43. Ohkubo T., Metoki H., Imai Y. Alcohol intake, circadian blood pressure variation, and stroke. Hypertension 2009, 53:4-5.
44. Reinke L.A., Moyer M.J. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metabolism and Disposition 1985, 13:548-552.
45. Reitman S., Frankel S.A. Colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology 1957, 28:56-63.
46. Rintala J., Jaatinen P., Parkkila S., Sarviharju M., Kiianmaa K., Hervonen A., et al. Evidence of acetaldehyde-protein adduct formation in rat brain after lifelong consumption of ethanol. Alcohol and Alcoholism 2000, 35:458-463.
47. Salaspuro M. Epidemiological aspects of alcoholic liver disease, ethanol metabolism and pathogenesis of alcoholic liver injury. Oxford text book of clinical hepatology 1999, 1157-1178. Oxford University Press, Oxford. J. Bircher, J.P. Benhamou, N. McIntyre, M. Rizzetto, J. Rodés (Eds.).
48. Sehrawat A., Sultana S. Evaluation of possible mechanisms of protective role of Tamarix gallica against DEN initiated and 2-AAF promoted hepatocarcinogenesis in male Wistar rats. Life Sciences 2006, 79:1456-1465.
49. Seitz H.K., Becker P. Alcohol metabolism and cancer risk. Alcohol Research & Health 2007, 30:38-47.
50. Tahir M., Sultana S. Chrysin modulates ethanol metabolism in Wistar rats: a promising role against organ toxicities. Alcohol and Alcoholism 2011, 46:383-392.
51. Tanaka T., Makita H., Kawabata K., Mori H., Kakumoto M., Satoh K., et al. Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. Carcinogenesis 1997, 18:761-769.
52. Wright J.R., Colby H.D., Miles P.R. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Archives of Biochemistry and Biophysics 1981, 206:296-304.
53. Zima T., Fialova L., Mestek O., Janebova M., Crkovska J., Malbohan I., et al. Oxidative stress, metabolism of ethanol and alcohol-related diseases. Journal of Biomedical Science 2001, 1:59-70.